drugset / Trial / NCT05511948
Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos
RandomizedSequentialTriple-blindTreatment
Summary
This is a randomized, observer-blinded, vehicle-controlled multi-dose trial that examines the effect of twice daily application of 0.8% DBI-102 Gel, 4% Hydroquinone cream, and Vehicle Gel for 12 weeks in adults with Fitzpatrick Skin Types IV-V and a colorimeter L\* measurement between 57.8 and 46.1.
Timeline
- Start
- 2022-08-18
- Primary completion
- 2023-03-07
- Completion
- 2023-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DBI-102 | Unknown | 0.8 % | Topical |
| Comparator | Hydroquinone | Small molecule | 4 % | — |